NDC 39892-0830-01 - MediChoice Triple Antibiotic
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 39892-0830
- Requested NDC
- 39892-0830-01
- Package NDCs from labels
- 39892-0830-1, 39892-0830-01
- Manufacturer
- O&M HALYARD, INC. | Owens & Minor, Inc
- Effective date
- 2025-10-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MediChoice Triple Antibiotic - O&M HALYARD, INC. | Owens & Minor, Inc | O&M HALYARD, INC. | Owens & Minor, Inc | 2025-10-09 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 39892-0830-1 | MediChoice Triple Antibiotic | 144 in 1 CARTON | OINTMENT | 144 | 6 | |
| 39892-0830-1 | MediChoice Triple Antibiotic | 0.9 g in 1 PACKET | OINTMENT | 0.9 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 39892-0830 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20231210_8369f399-6f64-4441-be72-1f16c7306c0a.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BACITRACIN | ACTIVE INGREDIENT | 58H6RWO52I | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| NEOMYCIN SULFATE | ACTIVE INGREDIENT | 057Y626693 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| POLYMYXIN B SULFATE | ACTIVE INGREDIENT | 19371312D4 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| BACITRACIN | ACTIVE MOIETY | 58H6RWO52I | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| NEOMYCIN | ACTIVE MOIETY | I16QD7X297 | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| POLYMYXIN B | ACTIVE MOIETY | J2VZ07J96K | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | MEDICHOICE TRIPLE ANTIBIOTIC (BACITRACIN) OINTMENT [OWENS & MINOR INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| First Aid Antibiotic plus Burn Relief | BACITRACINZINC,NEOMYCINSULFATE,POLYMXINBSULFATE,PRAMOXINEHCI | Trifecta Pharmaceuticals USA LLC | 048871e2-c917-292d-e063-6394a90af130 | 2024-12-18 | Warnings | M004 057Y626693 19371312D4 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c50cc6ad-e8a0-47c1-e053-2a95a90a4de6 | 2024-12-18 | Warnings | 4T6H12BN9U |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | fe18fa61-83f9-8bf9-e053-6294a90a7585 | 2024-12-18 | Warnings | 4T6H12BN9U |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c59dcb2a-392b-670b-e053-2995a90a9682 | 2024-12-18 | Warnings | 4T6H12BN9U |
| TheraCare Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | Veridian Healthcare | 0c3fc798-9a97-5316-e063-6394a90a6830 | 2024-12-18 | Warnings | M004 204602 057Y626693 19371312D4 |
| TheraCare Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Veridian Healthcare | fab95657-d257-e671-e053-6294a90a59e0 | 2024-12-18 | Warnings | 4T6H12BN9U |
| Meijer Petroleum Jelly | WHITE PETROLATUM | Meijer Distribution, Inc | b299cf2a-2c6a-68f4-e053-2995a90a5bd7 | 2024-12-18 | Warnings | 4T6H12BN9U |
| Caring Mills Petroleum Jelly | WHITE PETROLATUM | Veridian Healthcare | fbbfa780-0e2b-1874-e053-6394a90a5eeb | 2024-12-18 | Warnings | 4T6H12BN9U |
| TheraCare Petroleum Jelly | WHITE PETROLATUM | Veridian Healthcare | d6fad49b-8a49-7f7c-e053-2a95a90ae638 | 2024-12-18 | Warnings | 4T6H12BN9U |
| Shea Butter Petroleum Jelly | PETROLATUM JELLY | Walgreens | e35d913e-2195-4e3d-ae38-f010317140fd | 2024-12-17 | Warnings | 4T6H12BN9U |
| Jell Pharmaceuticals Vitamin A D | PETROLATUM | Jell Pharmaceuticals Pvt. Ltd. | 6ab8ba54-3679-4fd0-a876-cb89aace96ca | 2024-12-17 | Warnings | 4T6H12BN9U |
| Shea Butter Petroleum Jelly | PETROLATUM JELLY | Jell Pharmaceuticals Pvt. Ltd. | cd848f33-e863-d3af-e053-2a95a90a45b1 | 2024-12-17 | Warnings | 4T6H12BN9U |
| Recticare Advanced | LIDOCAINE AND MINERAL OIL AND PHENYLEPHRINE HCL AND WHITE PETROLATUM | Ferndale Laboratories, Inc. | 209212a7-7b6e-4b26-9f31-0eeb76f026bf | 2024-12-17 | Warnings | 4T6H12BN9U |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Rugby | a5b5e0a9-eee9-2a1e-e053-2a95a90a464e | 2024-12-17 | Warnings | 4T6H12BN9U |
| Bacitracin Zinc | BACITRACIN ZINC | Rugby Laboratories | ac3c9897-c812-1360-e053-2a95a90ad591 | 2024-12-17 | Warnings | M004 |
| Major Bacitracin | BACITRACIN ZINC | Major Pharmaceuticals | a23ce772-7078-0a4b-e053-2995a90aff0d | 2024-12-17 | Warnings | M004 |
| White Petrolatum | PETROLATUM | Geri-Care Pharmaceuticals, Corp | f40a29c2-65ea-91f9-e053-2a95a90ac439 | 2024-12-17 | Warnings | 4T6H12BN9U |
| Vitamin A and D | PETROLATUM | Geri-care Pharmaceutials Corp | fd76c101-a287-f92c-e053-6294a90a4468 | 2024-12-17 | Warnings | 4T6H12BN9U |
| Bacitracin Zinc | BACITRACIN ZINC | Trifecta Pharmaceuticals USA LLC | eea0d90c-914b-2624-e053-2a95a90a34c9 | 2024-12-13 | Warnings | M004 |
| OP First Aid Series TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | cadebf07-dd48-4855-8296-7a91e28d7123 | 2024-12-05 | Warnings | M004 204602 057Y626693 19371312D4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.